KUBio™ Box Modular Environments For Biomanufacturing Capacity
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.
Accelerate the production of viral vector-based therapies
The KUBio™ box modular environment for viral vectors is designed specifically for efficiently manufacturing adeno-associated virus (AAV) and lentivirus-based biotherapeutics. This BSL-2 environment uses the FlexFactory™ platform for viral vector single-use workflows designed to deliver flexibility and reduce contamination risk. The KUBio™ box footprint can also be expanded as production needs change.
Respond quickly to mRNA capacity needs
The KUBio™ box for mRNA is designed for the manufacture of mRNA molecules in a BSL-1 environment. A modular environment allows you to save time and money by using your existing or repurposed spaces to start manufacturing faster. Enhance your flexibility with an expandable and reproducible segregated biomanufacturing environment. Use a flexible FlexFactory™ platform for future scale up or scale out needs.
FlexFactory™ platform: the core of KUBio™ box environments
Once the KUBio™ box modular environment is in place, we implement a FlexFactory™ single-use biomanufacturing platform that’s configured to your specific processes and needs. Process requirements are balanced for batch scale and multiproduct capacity demands. FlexFactory™ platform gives you end-to-end services, integrated automation, and project management from design through qualification and beyond.
Gain maximum flexibility and efficiency
KUBio™ modular biomanufacturing environments reduce time to market, which delay the need to make critical capacity decisions early in the drug development cycle. With a history of successful installations across the globe, this comprehensive solution provides proven technical expertise and in-country assistance to resolve the unexpected.
Begin manufacturing faster for a fraction of the cost
Select one of the flexible, prefabricated cGMP biomanufacturing environment with a configurable production line that future-proofs capacity expansion, improves operational efficiency and minimizes infrastructure.